Showing results (311-320 of 425) with videos related to
Sort By:
Pageof 43
International Journal of Radiation Oncology, Biology, Physics|June 22, 2018
Long-Term Impact of Regional Nodal Irradiation in Patients With Node-Positive Breast Cancer Treated With Neoadjuvant Systemic TherapyShane R Stecklein, Minjeong Park, Diane D Liu, et al.Annals of Surgery|January 8, 2013
Impact of chemotherapy sequencing on local-regional failure risk in breast cancer patients undergoing breast-conserving therapyElizabeth A Mittendorf, Thomas A Buchholz, Susan L Tucker, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 16, 2011
Novel staging system for predicting disease-specific survival in patients with breast cancer treated with surgery as the first intervention: time to modify the current American Joint Committee on Cancer staging systemMin Yi, Elizabeth A Mittendorf, Janice N Cormier, et al.Clinical Immunology (Orlando, Fla.)|March 26, 2018
Phase Ib trial of folate binding protein (FBP)-derived peptide vaccines, E39 and an attenuated version, E39': An analysis of safety and immune responseTimothy J Vreeland, Jennifer K Litton, Na Qiao, et al.Annals of Surgical Oncology|January 8, 2021
Prospective Registry Trial Assessing the Use of Magnetic Seeds to Locate Clipped Nodes After Neoadjuvant Chemotherapy for Breast Cancer PatientsJanine M Simons, Marion E Scoggins, Henry M Kuerer, et al.Nature|June 25, 2015
Glypican-1 identifies cancer exosomes and detects early pancreatic cancerSonia A Melo, Linda B Luecke, Christoph Kahlert, et al.JCO Oncology Practice|May 16, 2023
Identifying Patterns and Barriers in OncotypeDX Recurrence Score Testing in Older Patients With Early-Stage, Estrogen Receptor-Positive Breast Cancer: Implications for Guidance and ReimbursementDario Trapani, Qingchun Jin, Caroline C Block, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2008
Combined clinical trial results of a HER2/neu (E75) vaccine for the prevention of recurrence in high-risk breast cancer patients: U.S. Military Cancer Institute Clinical Trials Group Study I-01 and I-02George E Peoples, Jarrod P Holmes, Matthew T Hueman, et al.Cancer Research|August 19, 2017
Trastuzumab Increases HER2 Uptake and Cross-Presentation by Dendritic CellsVictor A Gall, Anne V Philips, Na Qiao, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 23, 2022
Tumor Immune Microenvironment Changes by Multiplex Immunofluorescence Staining in a Pilot Study of Neoadjuvant Talazoparib for Early-Stage Breast Cancer Patients with a Hereditary BRCA MutationTapsi Kumar, Evie Hobbs, Fei Yang, et al.Pageof 43